Introduction:
The pharmaceutical industry in Belgium continues to thrive, with a focus on biologics manufacturing leading the way in 2026. With a growing demand for innovative biologic therapies, Belgium has become a key player in the global market. In 2025, the biologics market in Belgium experienced a 10% growth, reaching a total market size of $2.5 billion.
Top 10 Biologics Manufacturers in Belgium 2026:
1. Janssen Pharmaceuticals
Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, leads the biologics manufacturing industry in Belgium with a production volume of 500,000 units per year. Their cutting-edge research and development in biologic therapies have made them a key player in the global market.
2. UCB Biopharma
UCB Biopharma is another major player in the Belgian biologics manufacturing sector, with a market share of 20%. Their focus on developing biologic treatments for severe diseases such as rheumatoid arthritis and Crohn’s disease has positioned them as a leader in the industry.
3. Pfizer Belgium
Pfizer Belgium is known for its high-quality biologics production, with exports reaching $1 billion in 2025. Their commitment to innovation and research has solidified their position as one of the top biologics manufacturers in Belgium.
4. GSK Vaccines
GSK Vaccines, a division of GlaxoSmithKline, specializes in the production of vaccines and biologics. With a trade value of $800 million in 2025, they are a key player in the Belgian biologics market.
5. Ablynx
Ablynx is a biopharmaceutical company known for its innovative nanobody technology. With a production volume of 300,000 units per year, they have made significant contributions to the biologics manufacturing industry in Belgium.
6. TiGenix
TiGenix focuses on developing innovative cell therapies for a range of medical conditions. Their market share of 15% in Belgium highlights their growing influence in the biologics sector.
7. ThromboGenics
ThromboGenics is a biopharmaceutical company specializing in the development of biologic treatments for eye diseases. With exports reaching $500 million in 2025, they are a key player in the Belgian biologics market.
8. Galapagos
Galapagos is a biotechnology company known for its research and development in biologic therapies. Their collaborations with international partners have helped them expand their presence in the global biologics market.
9. Mithra Pharmaceuticals
Mithra Pharmaceuticals focuses on developing innovative hormonal therapies for women’s health. With a production volume of 200,000 units per year, they are a key player in the Belgian biologics manufacturing industry.
10. IBA Molecular
IBA Molecular specializes in the production of radiopharmaceuticals for medical imaging. Their technological advancements have positioned them as a leading biologics manufacturer in Belgium.
Insights:
Looking ahead to the future of biologics manufacturing in Belgium, it is clear that innovation and research will continue to drive growth in the industry. With an estimated market size of $3 billion by 2030, Belgium is poised to become a key player in the global biologics market. Collaboration between industry leaders and academic institutions will be crucial in driving advancements in biologic therapies and meeting the growing demand for innovative treatments. As Belgium continues to invest in research and development, we can expect to see even more companies emerging as top biologics manufacturers in the coming years.
Related Analysis: View Previous Industry Report
